Publications

1. Jin N, Kolliputi N, Gou D, Weng T, Liu L. A novel functions of ionotropic gamma-aminobutyric acid receptors involving alveolar fluid homeostasis. J Biol Chem. 2006; 281: 36012-20. PMCID: 17003036
2. Bhaskaran M, Kolliputi N, Wang Y, Gou D, Chintagari NR, Liu L.Trans-differentiation of alveolar epithelial type II cells to type I cells involves autocrine signaling by transforming growth factor beta 1 through the Smad pathway. J Biol Chem. 2007; 282: 3968-76. PMCID: 17158884
3. Kolliputi N and Waxman AB. The protective effect of IL-6 in hyperoxic acute lung injury is associated with SOCS through ASK-1 degradation. Am J Respir Cell Mol Biol. 2009; 40:314-24. PMCID: PMC2645529
4. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, Waxman AB. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res. 2009;104:236-44 PMCID: 19074475
5. Kolliputi N, Waxman AB. IL-6 cytoprotection in hyperoxic acute lung injury occurs via PI3K/Akt-mediated Bax phosphorylation. Am J Physiol Lung Cell Mol Physiol. 2009; 297: 6-16. PMCID: PMC2711806
6. Waxman AB, Kolliputi N. IL-6 protects against hyperoxia induced mitochondrial damage via BCL-2 induced BAK interactions with mitofusions. Am J Respir Cell Mol Biol. 2009;41(4):385-96. PMCID: PMC2746985
7. Kolliputi N, Shaik R, and Waxman AB. The Inflammasome Mediates Hyperoxia-Induced Alveolar Cell Permeability. J. Immunol. 2010; 184:5819-26. PMCID: PMC3780794
8. Kolliputi N, Galam L, Parthasarathy PT, Tipparaju SM, Lockey R. NALP3 Inflammasome Silencing Attenuates Ceramide Induced Transepithelial Permeability J Cell Physiol. 2011 Dec 14. 227:3310-6. doi: 10.1002/jcp.24026.  PMCID:    22169929
9. Aljubran SA, Cox R Jr, Tamarapu Parthasarathy P, Kollongod Ramanathan G, Rajanbabu V, Bao H, Mohapatra SM, Lockey R, Kolliputi N. Enhancer of Zeste Homolog 2 induces Pulmonary Artery Smooth Muscle Cell Proliferation, PLoS One. 2012;7(5):e37712. Epub 2012 May 25. PMCID: PMC3360676
10. Fukumoto J, Fukumoto I, Parthasarathy PT, Cox R, Huynh B, Ramanathan GK, Venugopal RB, Allen-Gipson DS, Lockey RF, Kolliputi N. NLRP3 Deletion Protects from Hyperoxia-Induced Acute Lung Injury. Am J Physiol Cell Physiol. 2013 May 1. 305:C182-189. PMID: 23636457 [PubMed] PMCID: PMC3725631
11. Desai P, Tamarapu Parthasarathy P, Galam L, Lockey R, Kolliputi N. A new role for inflammasomes: sensing the disturbances in non-alcoholic fatty liver disease. Front Physiol. 2013 Jul 1;4:156. doi: 10.3389/fphys.2013.00156 PMID: 23847540 [PubMed] PMCID: PMC3696836
12. Lagishetty V, Parthasarathy PT, Phillips O, Fukumoto J, Cho Y, Fukumoto I, Bao H, Cox R Jr, Galam L, Lockey RF, Kolliputi N. Dysregulation of CLOCK gene expression in hyperoxia-induced lung injury. Am J Physiol Cell Physiol. 2014 Jun 1;306(11):C999-C1007. doi: 10.1152/ajpcell.00064.2013. Epub 2014 Apr 2. PMID: 24696144
13. Saco TV, Parthasarathy PT, Cho Y, Lockey RF, Kolliputi N. Role of epigenetics in pulmonary hypertension. Am J Physiol Cell Physiol. 2014 Jun 15;306(12):C1101-5.. PMID: 24717578
14. 15. Turn CS, Kolliputi N. Two Sides of a Coin: The Dual Roles of Chitinase 3-Like 1 in Idiopathic Pulmonary Fibrosis. Lung. 2014 Oct 1. PMID: 25270518
15. Chapalamadugu KC, Panguluri SK, Bennett ES, Kolliputi N, Tipparaju SM. High level of oxygen treatment causes cardiotoxicity with arrhythmias and redox modulation. Toxicol Appl Pharmacol. 2015 Jan 1;282(1):100-7. PMID: 25447406